» Articles » PMID: 18978253

Prescription Patterns of Psychotropic Medications in Elderly Compared with Younger Participants Who Achieved a "recovered" Status in the Systematic Treatment Enhancement Program for Bipolar Disorder

Overview
Publisher Elsevier
Specialty Geriatrics
Date 2008 Nov 4
PMID 18978253
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study compares prescription patterns between young adults and elderly with bipolar disorder who achieved a recovery status during the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Design: STEP-BD is a multicenter National Institute of Mental Health-funded project designed to evaluate the longitudinal outcome of patients with bipolar disorder. The STEP-BD study involved extensive assessment across multiple domains including demographic data, diagnosis, symptom severity, treatment, and clinical status. Patients achieved "recovered" status when they experienced eight consecutive weeks without significant symptoms.

Participants: The authors analyzed data of all subjects who achieved a recovered status at least once in their participation.

Measurements: The authors compared treatment regimes and doses among young participants with middle age (N = 3,364), 20-59 years old, and older participants 60 and above (N = 246).

Results: Of the 3,615 STEP-BD participants who had a lifetime diagnosis of bipolar subtypes I or II, 67.6% (N = 2442) achieved a recovered status during their participation. A total of 78.5% (N = 193) of older patients recovered compared with 66.8% of the younger cohort. On average, participants who reached a recovered status took 2.05 medications with no difference between age groups. Lithium was prescribed to 37.8% of younger patients compared with only 29.5% of older participants. The mean dosages taken by younger and older patients differed significantly only for lithium, valproate, and risperidone with elderly individuals prescribed lower daily dosages. Significant reduction in lithium dosing was observed among individuals aged 50 and older and among individuals 60 and older for valproate. Although valproate was more often prescribed, 42.1% of recovered bipolar elder achieved recovery with lithium alone compared with only 21.3% of the younger cohort.

Conclusion: This data shows recovery is achievable in the elderly though more than one medication is often needed regardless of age.

Citing Articles

Bipolar Disorder Among Older Adults: Newer Evidence to Guide Clinical Practice.

Dols A, Sekhon H, Rej S, Klaus F, Bodenstein K, Sajatovic M Focus (Am Psychiatr Publ). 2024; 21(4):370-379.

PMID: 38695001 PMC: 11058954. DOI: 10.1176/appi.focus.20230010.


International Trends in Lithium Use for Pharmacotherapy and Clinical Correlates in Bipolar Disorder: A Scoping Review.

Shuy Y, Santharan S, Chew Q, Sim K Brain Sci. 2024; 14(1).

PMID: 38275522 PMC: 10813799. DOI: 10.3390/brainsci14010102.


Facts and myths about the use of lithium for bipolar disorder in routine clinical practice: an expert consensus paper.

Fiorillo A, Sampogna G, Albert U, Maina G, Perugi G, Pompili M Ann Gen Psychiatry. 2023; 22(1):50.

PMID: 38057894 PMC: 10702081. DOI: 10.1186/s12991-023-00481-y.


Characteristics of Bipolar Patients with Cognitive Impairment of Suspected Neurodegenerative Origin: A Multicenter Cohort.

Musat E, Marlinge E, Leroy M, Olie E, Magnin E, Lebert F J Pers Med. 2021; 11(11).

PMID: 34834535 PMC: 8620397. DOI: 10.3390/jpm11111183.


Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: Analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project.

Sajatovic M, Dols A, Rej S, Almeida O, Beunders A, Blumberg H Bipolar Disord. 2021; 24(2):195-206.

PMID: 34314549 PMC: 8792096. DOI: 10.1111/bdi.13119.


References
1.
Tohen M, Jacobs T, Grundy S, McElroy S, Banov M, Janicak P . Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry. 2000; 57(9):841-9. DOI: 10.1001/archpsyc.57.9.841. View

2.
Sajatovic M, Blow F, Kales H, Valenstein M, Ganoczy D, Ignacio R . Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int J Geriatr Psychiatry. 2007; 22(10):992-8. DOI: 10.1002/gps.1777. View

3.
Tohen M, Chengappa K, Suppes T, Zarate Jr C, Calabrese J, Bowden C . Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry. 2002; 59(1):62-9. DOI: 10.1001/archpsyc.59.1.62. View

4.
Sachs G, Grossman F, Ghaemi S, Okamoto A, Bowden C . Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry. 2002; 159(7):1146-54. DOI: 10.1176/appi.ajp.159.7.1146. View

5.
Sachs G, Guille C, McMurrich S . A clinical monitoring form for mood disorders. Bipolar Disord. 2002; 4(5):323-7. DOI: 10.1034/j.1399-5618.2002.01195.x. View